EVH (Evolent Health) Ending Cash Position: $169 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EVH Evolent Health Inc EVH
64 GF Score
Price $3.07
GF Value $11.51
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Evolent Health Ending Cash Position?

Evolent Health EVH -3.62% 64 Ending Cash Position is $169 Mil as of Mar. 2026. GuruFocus rates EVH with a GF Score™ of 64/100 and a GF Value™ of $11.51 (Possible Value Trap). The stock has 6 warning signs investors should review.

Evolent Health's Ending Cash Position for the quarter that ended in Mar. 2026 was $169 Mil.

Evolent Health's quarterly Ending Cash Position increased from Sep. 2025 ($143 Mil) to Dec. 2025 ($181 Mil) but then declined from Dec. 2025 ($181 Mil) to Mar. 2026 ($169 Mil).

Evolent Health's annual Ending Cash Position declined from Dec. 2023 ($223 Mil) to Dec. 2024 ($178 Mil) but then increased from Dec. 2024 ($178 Mil) to Dec. 2025 ($181 Mil).

Evolent Health Ending Cash Position Related Terms

Evolent Health Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Evolent Health's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evolent Health Ending Cash Position Chart

Evolent Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 354.94 215.16 223.46 178.50 180.70

Evolent Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 277.85 177.97 143.00 180.70 168.74
EVH
64GF Score
Evolent Health Inc EVH
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evolent Health Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Evolent Health's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=178.496+2.2
=181

Evolent Health's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=180.696+-11.952
=169

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $169 Mil mean?
Evolent Health (EVH) has a Ending Cash Position of $169 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Evolent Health and its competitors.
Is Evolent Health's Ending Cash Position too high?
Evolent Health's current Ending Cash Position is $169 Mil. Overall, Evolent Health has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Evolent Health's Ending Cash Position compare to NRC and SOPH?
Evolent Health's Ending Cash Position of $169 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Providers & Services company?
A good Ending Cash Position depends on the Healthcare Providers & Services industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Evolent Health and its competitors. Evolent Health's current Ending Cash Position is $169 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evolent Health stock overvalued right now?
Based on GuruFocus' analysis, Evolent Health (EVH) is currently considered Possible Value Trap. The stock's GF Value™ is $11.51, compared to a current price of $3.07 — trading 73.4% below its estimated fair value. The current Ending Cash Position is $169 Mil. Evolent Health's overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Evolent Health (EVH), the current Ending Cash Position is $169 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Evolent Health (EVH) Overvalued in 2026?

Based on GuruFocus' analysis, Evolent Health stock appears to be undervalued. The current stock price of $3.07 is trading 73.4% below its estimated GF Value™ of $11.51. GuruFocus considers Evolent Health to be Possible Value Trap.

Key valuation signals for EVH:

  • Ending Cash Position: $169 Mil
  • GF Value™: $11.51 vs. price of $3.07 (73.4% below fair value)
  • GF Score™: 64/100 with 6 warning signs

No single metric tells the full story. See the EVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Evolent Health Business Description

Other Exchanges 9EH:Germany
Address 1812 North Moore Street, Suite 1705, Arlington, VA, USA, 22209
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
64GF Score

Get the complete analysis for EVH

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.07
Price
$11.51
GF Value